GHR and cancer: A number of in vivo xenograft studies on bGH, GHRKO, as well as on mice transgenic for a GHR-antagonist (GHA mice) revealed an intrinsic resistance to tumor development and cancer progression due to abrogation of GHR function[2,3,86].